- Home
- OCTO vs LIPO Comparison
OCTO vs LIPO Comparison
Compare OCTO & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCTO
- LIPO
- Stock Information
- Founded
- OCTO 1966
- LIPO 2005
- Country
- OCTO United States
- LIPO United States
- Employees
- OCTO N/A
- LIPO N/A
- Industry
- OCTO
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- OCTO
- LIPO Health Care
- Exchange
- OCTO Nasdaq
- LIPO Nasdaq
- Market Cap
- OCTO 2.6M
- LIPO 3.1M
- IPO Year
- OCTO N/A
- LIPO 2022
- Fundamental
- Price
- OCTO $1.10
- LIPO $2.53
- Analyst Decision
- OCTO
- LIPO Strong Buy
- Analyst Count
- OCTO 0
- LIPO 1
- Target Price
- OCTO N/A
- LIPO $16.00
- AVG Volume (30 Days)
- OCTO 33.5K
- LIPO 45.5K
- Earning Date
- OCTO 05-15-2025
- LIPO 05-08-2025
- Dividend Yield
- OCTO N/A
- LIPO N/A
- EPS Growth
- OCTO N/A
- LIPO N/A
- EPS
- OCTO N/A
- LIPO N/A
- Revenue
- OCTO $39,835,256.00
- LIPO $536,357.00
- Revenue This Year
- OCTO N/A
- LIPO N/A
- Revenue Next Year
- OCTO N/A
- LIPO N/A
- P/E Ratio
- OCTO N/A
- LIPO N/A
- Revenue Growth
- OCTO N/A
- LIPO 19.29
- 52 Week Low
- OCTO $1.02
- LIPO $2.02
- 52 Week High
- OCTO $4.86
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- OCTO 39.27
- LIPO 46.60
- Support Level
- OCTO $1.05
- LIPO $2.13
- Resistance Level
- OCTO $1.33
- LIPO $2.74
- Average True Range (ATR)
- OCTO 0.07
- LIPO 0.21
- MACD
- OCTO 0.02
- LIPO 0.05
- Stochastic Oscillator
- OCTO 17.59
- LIPO 67.61
About OCTO Eightco Holdings Inc.
Eightco Holdings Inc operates in three main businesses: Forever 8 Inventory Cash Flow Solution, Web3 Business, and Packaging Business. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Web3 Business but has no intention of continuing this business at this time. The Packaging Business manufactures and sells custom packaging for a wide variety of products and helps customers generate brand awareness and promote brand image through packaging. The Company's two reportable segments were the Inventory Management Solutions segment and the Corrugated segment. Key revenue is generated from Inventory Management Solutions segment.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.